📰 Platform Technology News
Page 21 - Platform Technology News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Platform Technology. Real-time updates on events, politics, business and more.
January 4, 2023
/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...
January 4, 2023
/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...
January 4, 2023
Synaffix to provide Hummingbird Bioscience access to proprietary ADC technologies Synaffix to receive up to $150m in upfront and milestone payments plus royalties SAN FRANCISCO, HOUSTON and SINGAPORE, Jan. 4, 2023 /PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, and Hummingbird Bioscience (Hummingbird Bio), a data-driven p...
December 22, 2022
/PRNewswire/ -- Sinoveda is an innovative health brand committed to bringing the strengths of Eastern and Western medicine together. The company has used its...
December 22, 2022
/PRNewswire/ -- Pain relief is a subject that everyone can relate to. It doesnt matter if they are a middle-aged man dealing with a golfers elbow, a young...
December 13, 2022
AMSTERDAM, Dec. 13, 2022 /PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug
December 13, 2022
/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...
December 9, 2022
-- 100% ORR at both CART-ddBCMA dose levels; deep and durable responses observed in patients with poor prognostic factors -- -- 27 of 38 (71%) evaluable...
November 30, 2022
BUFFALO, N.Y., Nov. 30, 2022 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a Buffalo, New York-based biopharmaceutical startup, announces the...
November 29, 2022
/PRNewswire/ -- The health and wellness industry is currently suffering from an excess of pain relief options. From dangerously strong NSAIDs to highly...